BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: . European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options. Br J Ophthalmol 2017;101:130-95. [PMID: 28559477 DOI: 10.1136/bjophthalmol-2016-EGSguideline.003] [Cited by in Crossref: 99] [Cited by in F6Publishing: 41] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 DI Staso S, Agnifili L, Ciancaglini M, Murano G, Borrelli E, Mastropasqua L. In Vivo Scanning Laser Confocal Microscopy of Conjunctival Goblet Cells in Medically-controlled Glaucoma. In Vivo 2018;32:437-43. [PMID: 29475934 DOI: 10.21873/invivo.11259] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Phu J, Kalloniatis M. The Frontloading Fields Study (FFS): Detecting Changes in Mean Deviation in Glaucoma Using Multiple Visual Field Tests Per Clinical Visit. Transl Vis Sci Technol 2021;10:21. [PMID: 34779836 DOI: 10.1167/tvst.10.13.21] [Reference Citation Analysis]
3 Lerner SF, Oddone F, Lu DW, Sanseau A, Guarro M, Ridolfi A, Hubatsch D. Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension. Clin Ophthalmol 2019;13:2411-9. [PMID: 31824135 DOI: 10.2147/OPTH.S228777] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R. Switching from concomitant therapy to tafluprost/timolol fixed combination. Clin Ophthalmol 2018;12:549-54. [PMID: 29606852 DOI: 10.2147/OPTH.S150595] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Nakazawa T, Takahashi K, Kuwayama Y, Nomura A, Shimada F. Interim Results of Post-Marketing Observational Study of Omidenepag Isopropyl for Glaucoma and Ocular Hypertension in Japan. Adv Ther. [DOI: 10.1007/s12325-021-02035-8] [Reference Citation Analysis]
6 Costagliola C, Sbordone M, Gandolfi S, Cesari L, Furneri G, Fea AM. Minimally Invasive Surgery in Mild-to-Moderate Glaucoma Patients in Italy: Is It Time to Change? Clin Ophthalmol 2020;14:2639-55. [PMID: 32982157 DOI: 10.2147/OPTH.S264839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Jung Y, Suh H, Moon JI. Differential impact of prostaglandin analogues on agreement of intraocular pressure measurements obtained by Goldmann applanation, rebound, and noncontact tonometry. BMC Ophthalmol 2021;21:436. [PMID: 34915877 DOI: 10.1186/s12886-021-02211-y] [Reference Citation Analysis]
8 Itoh K, Ida Y, Ohguro H, Hikage F. Prostaglandin F2α agonists induced enhancement in collagen1 expression is involved in the pathogenesis of the deepening of upper eyelid sulcus. Sci Rep 2021;11:9002. [PMID: 33903711 DOI: 10.1038/s41598-021-88562-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fingeret M, Dickerson JE Jr. The Role of Minimally Invasive Glaucoma Surgery Devices in the Management of Glaucoma. Optom Vis Sci 2018;95:155-62. [PMID: 29370021 DOI: 10.1097/OPX.0000000000001173] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
10 Itoh K, Hikage F, Ida Y, Ohguro H. Prostaglandin F2α Agonists Negatively Modulate the Size of 3D Organoids from Primary Human Orbital Fibroblasts. Invest Ophthalmol Vis Sci 2020;61:13. [PMID: 32503053 DOI: 10.1167/iovs.61.6.13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
11 Contreras-Salinas H, Barajas-Hernández M, Baiza-Durán LM, Vázquez-Álvarez AO, Bautista-Castro MA, Rodríguez-Herrera LY. Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination. Clin Ophthalmol 2021;15:583-90. [PMID: 33623359 DOI: 10.2147/OPTH.S288180] [Reference Citation Analysis]
12 Smith M, Bresolin M, McCabe R. Pilot Study of Clinician-Patient Collaboration in Glaucoma. Clin Ophthalmol 2021;15:1715-26. [PMID: 33935488 DOI: 10.2147/OPTH.S292347] [Reference Citation Analysis]
13 Sohajda Z, Széll N, Revák Á, Papp J, Tóth-Molnár E. Retinal Nerve Fibre Layer Thickness Change After CO2 Laser-Assisted Deep Sclerectomy Surgery. Clin Ophthalmol 2020;14:1749-57. [PMID: 32612350 DOI: 10.2147/OPTH.S247595] [Reference Citation Analysis]
14 Lin Y, Huang S, Chuang L, Chen L. Retinal Vessel Density Changes on Optical Coherence Tomography Angiography and Predictive Factors in Normal-Tension Glaucoma Treated with Topical Beta-Blocker. Sci Pharm 2021;89:40. [DOI: 10.3390/scipharm89030040] [Reference Citation Analysis]
15 Erb C, Stalmans I, Iliev M, Muñoz-Negrete FJ. Real-World Study on Patient Satisfaction and Tolerability After Switching to Preservative-Free Latanoprost. Clin Ophthalmol 2021;15:931-8. [PMID: 33688161 DOI: 10.2147/OPTH.S295821] [Reference Citation Analysis]
16 Esaki Y, Katsuta O, Kamio H, Noto T, Mano H, Iwamura R, Yoneda K, Odani-Kawabata N, Morishima K, Shams NK. The Antiglaucoma Agent and EP2 Receptor Agonist Omidenepag Does Not Affect Eyelash Growth in Mice. J Ocul Pharmacol Ther 2020;36:529-33. [PMID: 32412835 DOI: 10.1089/jop.2020.0003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
17 Marolo P, Reibaldi M, Fallico M, Maugeri A, Barchitta M, Agodi A, Parisi G, Caselgrandi P, Ventre L, Ahmed IIK. Reintervention rate in glaucoma filtering surgery: A systematic review and meta-analysis. Eur J Ophthalmol 2022;:11206721221093828. [PMID: 35473447 DOI: 10.1177/11206721221093828] [Reference Citation Analysis]
18 Teus MA, Belda JI, Lavín C, Garcã­a-feijoã J, Falvey H, Buseghin G, Soler M, Appierto M. Cost-effectiveness analysis of iStent Inject® implantation during cataract surgery compared to cataract surgery alone for mild to moderate open-angle glaucoma patients in Spain. Expert Review of Ophthalmology 2021;16:319-28. [DOI: 10.1080/17469899.2021.1939685] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pyfer MF, Gallardo M, Campbell A, Flowers BE, Dickerson JE Jr, Talla A, Dhamdhere K. Suppression of Diurnal (9AM-4PM) IOP Fluctuations with Minimally Invasive Glaucoma Surgery: An Analysis of Data from the Prospective, Multicenter, Single-Arm GEMINI Study. Clin Ophthalmol 2021;15:3931-8. [PMID: 34594099 DOI: 10.2147/OPTH.S335486] [Reference Citation Analysis]
20 Fea AM, Cattel F, Gandolfi S, Buseghin G, Furneri G, Costagliola C. Cost-utility analysis of trabecular micro-bypass stents (TBS) in patients with mild-to-moderate open-angle Glaucoma in Italy. BMC Health Serv Res 2021;21:824. [PMID: 34399759 DOI: 10.1186/s12913-021-06862-x] [Reference Citation Analysis]
21 Olander KW, Sato MA, Abrams MA, Jerkins GW, Lu F, Dinh P, Odani-Kawabata N, Chabi A, Shams NK. A Randomized Phase 2 Trial Comparing Omidenepag Isopropyl 0.002% Once and Twice Daily in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension (SPECTRUM-6). J Glaucoma 2021;30:473-80. [PMID: 33813559 DOI: 10.1097/IJG.0000000000001836] [Reference Citation Analysis]
22 Tachkov K, Vassilev A, Kostova S. Modeling the Pharmacotherapy Cost and Outcomes of Primary Open-Angle Glaucoma With Dry Eye. Front Public Health 2019;7:363. [PMID: 31921735 DOI: 10.3389/fpubh.2019.00363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Grzybowski A, Och M, Kanclerz P, Leffler C, Moraes CG. Primary Open Angle Glaucoma and Vascular Risk Factors: A Review of Population Based Studies from 1990 to 2019. J Clin Med 2020;9:E761. [PMID: 32168880 DOI: 10.3390/jcm9030761] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
24 Sedlak L, Zych M, Wojnar W, Wyględowska-Promieńska D. Effect of Topical Prostaglandin F2α Analogs on Selected Oxidative Stress Parameters in the Tear Film. Medicina (Kaunas) 2019;55:E366. [PMID: 31336766 DOI: 10.3390/medicina55070366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
25 Michelessi M, Bicket AK, Lindsley K. Cyclodestructive procedures for non-refractory glaucoma. Cochrane Database Syst Rev 2018;4:CD009313. [PMID: 29694684 DOI: 10.1002/14651858.CD009313.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Lin YH, Huang SM, Yeung L, Ku WC, Chen HS, Lai CC, Chuang LH. Correlation of Visual Field With Peripapillary Vessel Density Through Optical Coherence Tomography Angiography in Normal-Tension Glaucoma. Transl Vis Sci Technol 2020;9:26. [PMID: 33364080 DOI: 10.1167/tvst.9.13.26] [Reference Citation Analysis]
27 Susanna BN, Ogata NG, Jammal AA, Susanna CN, Berchuck SI, Medeiros FA. Corneal Biomechanics and Visual Field Progression in Eyes with Seemingly Well-Controlled Intraocular Pressure. Ophthalmology 2019;126:1640-6. [PMID: 31519385 DOI: 10.1016/j.ophtha.2019.07.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 6.7] [Reference Citation Analysis]
28 Qian CX, Chen Q, Cun Q, Tao YJ, Yang WY, Yang Y, Hu ZY, Zhu YT, Zhong H. Comparison of the SITA Faster-a new visual field strategy with SITA Fast strategy. Int J Ophthalmol 2021;14:1185-91. [PMID: 34414082 DOI: 10.18240/ijo.2021.08.08] [Reference Citation Analysis]
29 Li F, Song D, Chen H, Xiong J, Li X, Zhong H, Tang G, Fan S, Lam DSC, Pan W, Zheng Y, Li Y, Qu G, He J, Wang Z, Jin L, Zhou R, Song Y, Sun Y, Cheng W, Yang C, Fan Y, Li Y, Zhang H, Yuan Y, Xu Y, Xiong Y, Jin L, Lv A, Niu L, Liu Y, Li S, Zhang J, Zangwill LM, Frangi AF, Aung T, Cheng CY, Qiao Y, Zhang X, Ting DSW. Development and clinical deployment of a smartphone-based visual field deep learning system for glaucoma detection. NPJ Digit Med 2020;3:123. [PMID: 33043147 DOI: 10.1038/s41746-020-00329-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Bouillot A, Pierru A, Blumen-Ohana E, Brasnu E, Baudouin C, Labbé A. Changes in choroidal thickness and optic nerve head morphology after filtering surgery: nonpenetrating deep sclerectomy versus trabeculectomy. BMC Ophthalmol 2019;19:24. [PMID: 30665377 DOI: 10.1186/s12886-019-1031-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Fiedorowicz E, Cieślińska A, Kuklo P, Grzybowski A. Protein Biomarkers in Glaucoma: A Review. J Clin Med 2021;10:5388. [PMID: 34830671 DOI: 10.3390/jcm10225388] [Reference Citation Analysis]
32 den Haan J, van de Kreeke JA, Konijnenberg E, ten Kate M, den Braber A, Barkhof F, van Berckel BN, Teunissen CE, Scheltens P, Visser PJ, Verbraak FD, Bouwman FH. Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease. Alzheimers Dement (Amst) 2019;11:463-71. [PMID: 31249859 DOI: 10.1016/j.dadm.2019.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
33 Atanasovska Velkovska M, Goričar K, Blagus T, Dolžan V, Cvenkel B. Association of Genetic Polymorphisms in Oxidative Stress and Inflammation Pathways with Glaucoma Risk and Phenotype. J Clin Med 2021;10:1148. [PMID: 33803434 DOI: 10.3390/jcm10051148] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Jammal AA, Thompson AC, Mariottoni EB, Estrela T, Shigueoka LS, Berchuck SI, Medeiros FA. Impact of Intraocular Pressure Control on Rates of Retinal Nerve Fiber Layer Loss in a Large Clinical Population. Ophthalmology 2021;128:48-57. [PMID: 32579892 DOI: 10.1016/j.ophtha.2020.06.027] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
35 Kelada M, Hill D, Yap TE, Manzar H, Cordeiro MF. Innovations and revolutions in reducing retinal ganglion cell loss in glaucoma. Expert Review of Ophthalmology 2021;16:33-46. [DOI: 10.1080/17469899.2021.1835470] [Reference Citation Analysis]
36 Cutolo CA, Bonzano C, Scotto R, Iester M, Bagnis A, Pizzorno C, Catti C, Traverso CE. Moving beyond the Slit-Lamp Gonioscopy: Challenges and Future Opportunities. Diagnostics (Basel) 2021;11:2279. [PMID: 34943516 DOI: 10.3390/diagnostics11122279] [Reference Citation Analysis]
37 van Mechelen RJS, Wolters JE, Bertens CJF, Webers CAB, van den Biggelaar FJHM, Gorgels TGMF, Beckers HJM. Animal models and drug candidates for use in glaucoma filtration surgery: A systematic review. Exp Eye Res 2022;:108972. [PMID: 35114212 DOI: 10.1016/j.exer.2022.108972] [Reference Citation Analysis]
38 Stalmans I, Lemij H, Clarke J, Baudouin C; GOAL study group. Signs and Symptoms of Ocular Surface Disease: The Reasons for Patient Dissatisfaction with Glaucoma Treatments. Clin Ophthalmol 2020;14:3675-80. [PMID: 33162751 DOI: 10.2147/OPTH.S269586] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Sakata R, Chang PY, Sung KR, Kim TW, Wang TH, Perera SA, Cantor LB. Prostaglandin-associated periorbitopathy syndrome (PAPS): Addressing an unmet clinical need. Semin Ophthalmol 2021;:1-8. [PMID: 34793279 DOI: 10.1080/08820538.2021.2003824] [Reference Citation Analysis]
40 Kong W, Zhang J, Lu C, Ding Y, Meng Y. Glaucoma in mucopolysaccharidoses. Orphanet J Rare Dis 2021;16:312. [PMID: 34266471 DOI: 10.1186/s13023-021-01935-w] [Reference Citation Analysis]
41 Wanichwecharungruang B, Ratprasatporn N. 24-month outcomes of XEN45 gel implant versus trabeculectomy in primary glaucoma. PLoS One 2021;16:e0256362. [PMID: 34411152 DOI: 10.1371/journal.pone.0256362] [Reference Citation Analysis]
42 Matsuo M, Matsuoka Y, Tanito M. Efficacy and Patient Tolerability of Omidenepag Isopropyl in the Treatment of Glaucoma and Ocular Hypertension. OPTH 2022;Volume 16:1261-79. [DOI: 10.2147/opth.s340386] [Reference Citation Analysis]
43 Jayaram H. Intraocular pressure reduction in glaucoma: Does every mmHg count? Taiwan J Ophthalmol 2020;10:255-8. [PMID: 33437597 DOI: 10.4103/tjo.tjo_63_20] [Reference Citation Analysis]
44 Romito N, Bluwol E, Graber M, Le Pape C, Lachkar Y. Argon Laser Iridoplasty For Plateau Iris Syndrome: Long-Term Outcomes of 48 Eyes. J Glaucoma 2019;28:767-71. [PMID: 31233455 DOI: 10.1097/IJG.0000000000001313] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Nieland K, Labbé A, Schweitzer C, Gicquel G, Kleintjens J, Ostawal A, Treur M, Falvey H. A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France. PLoS One 2021;16:e0252130. [PMID: 34111130 DOI: 10.1371/journal.pone.0252130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Nitta K, Tachibana G, Wajima R, Inoue S, Ohigashi T, Otsuka N, Kurashima H, Santo K, Hashimoto M, Shibahara H, Hirukawa M, Sugiyama K. Predicting Lifetime Transition Risk of Severe Visual Field Defects Using Monte Carlo Simulation in Japanese Patients with Primary Open-Angle Glaucoma. Clin Ophthalmol 2020;14:1967-78. [PMID: 32764862 DOI: 10.2147/OPTH.S247618] [Reference Citation Analysis]
47 Gan J, Sng CCA, Ke M, Chieh CS, Tan B, Schmetterer L, Ang M. Anterior Segment Optical Coherence Tomography Angiography Following Trabecular Bypass Minimally Invasive Glaucoma Surgery. Front Med 2022;9:830678. [DOI: 10.3389/fmed.2022.830678] [Reference Citation Analysis]
48 Pals J, Mensink HW, Brosens E, Verdijk RM, Naus NC, Paridaens DA, Kilic E, Ramdas WD. The Effect of Intraocular Pressure-Lowering Medication on Metastatic Uveal Melanomas. Cancers (Basel) 2021;13:5657. [PMID: 34830810 DOI: 10.3390/cancers13225657] [Reference Citation Analysis]
49 Vasile P, Valeria C, Speranţa S, Cătălina II, Miruna GB, Maria C, Dana MCD. Sympathetic context of the disease - a new era in glaucoma management. Rom J Ophthalmol 2021;65:15-9. [PMID: 33817428 DOI: 10.22336/rjo.2021.4] [Reference Citation Analysis]
50 Kansal V, Armstrong JJ, Hutnik CM. Trends in Glaucoma Filtration Procedures: A Retrospective Administrative Health Records Analysis Over a 13-Year Period in Canada. Clin Ophthalmol 2020;14:501-8. [PMID: 32109986 DOI: 10.2147/OPTH.S232873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
51 Wirta DL, Kuwayama Y, Lu F, Shao H, Odani-Kawabata N. Phase 2b, Randomized, 3-Month, Dose-Finding Study of Sepetaprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: The ANGEL Study. J Ocul Pharmacol Ther 2022. [PMID: 35167779 DOI: 10.1089/jop.2021.0077] [Reference Citation Analysis]
52 Bisorca-gassendorf L, Murovski S, Julich-härtel H, Rickmann A, Szabo JE, Erokhina M, Wenzel M, Januschowski K. Asynchronous Teleophthalmology for Monitoring Glaucoma Patients in a Rural German Region: A Retrospective Observational Pilot Study. Cureus. [DOI: 10.7759/cureus.24210] [Reference Citation Analysis]
53 da Silva PHR, Cunha Júnior ADS, Pianetti GA, Fernandes C. Chromatographic bioanalysis of antiglaucoma drugs in ocular tissues. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1166:122388. [PMID: 33578274 DOI: 10.1016/j.jchromb.2020.122388] [Reference Citation Analysis]
54 Karachalios D, Guthoff RF, Kundt G, Thiesen F, Kopp F, Siewert S, Koschmieder A, Jünemann A, Stahnke T. Assessment of the Efficacy of Microinvasive Glaucoma Surgery Techniques using an Oculopression Stress Test. Klin Monbl Augenheilkd 2020;237:1117-23. [PMID: 32967033 DOI: 10.1055/a-1214-3875] [Reference Citation Analysis]
55 Nuzzi R, Marolo P, Nuzzi A. The Hub-and-Spoke Management of Glaucoma. Front Neurosci 2020;14:180. [PMID: 32256306 DOI: 10.3389/fnins.2020.00180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Covello G, Loiudice P, Maglionico MN, Nardi M, Figus M, Posarelli C. Combined Phacoemulsification and Ex-PRESS Implant with Everting Suture in Primary Angle-Closure Glaucoma: Survival Analysis and Predictive Factors. J Clin Med 2021;10:774. [PMID: 33671999 DOI: 10.3390/jcm10040774] [Reference Citation Analysis]
57 Tapply I, Broadway DC. Improving Adherence to Topical Medication in Patients with Glaucoma. Patient Prefer Adherence 2021;15:1477-89. [PMID: 34239297 DOI: 10.2147/PPA.S264926] [Reference Citation Analysis]
58 Glatzel CM, Patzkó Á, Matlach J, Grehn F. [Results of filtering trabeculotomy (FTO) compared to conventional trabeculectomy (TE)-a matched case control study]. Ophthalmologe 2021;118:461-9. [PMID: 33779826 DOI: 10.1007/s00347-021-01365-w] [Reference Citation Analysis]
59 Shin YJ, Kim E, Han BK, Yi K. Serum Biomarkers for the Diagnosis of Glaucoma. Diagnostics (Basel) 2020;11:E20. [PMID: 33374330 DOI: 10.3390/diagnostics11010020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Garg A, Gazzard G. Treatment choices for newly diagnosed primary open angle and ocular hypertension patients. Eye (Lond) 2020;34:60-71. [PMID: 31685971 DOI: 10.1038/s41433-019-0633-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
61 Hanekamp S, Ćurčić-Blake B, Caron B, McPherson B, Timmer A, Prins D, Boucard CC, Yoshida M, Ida M, Hunt D, Jansonius NM, Pestilli F, Cornelissen FW. White matter alterations in glaucoma and monocular blindness differ outside the visual system. Sci Rep 2021;11:6866. [PMID: 33767217 DOI: 10.1038/s41598-021-85602-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Tatti F, Gentile P, Mangoni L, Demarinis G, Napoli P, Fossarello M. Xen45 gel stent ab interno trimming for ostium occlusion: case report. BMC Ophthalmol 2021;21:446. [PMID: 34961501 DOI: 10.1186/s12886-021-02207-8] [Reference Citation Analysis]
63 Chamard C, Daien V, Han H, Greenfield DS, Villain M. Efficacy and safety of ultrasonic circular cyclocoagulation with second-generation probe in glaucoma: A retrospective study. PLoS One 2020;15:e0227389. [PMID: 31978165 DOI: 10.1371/journal.pone.0227389] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Nakamura N, Honjo M, Yamagishi R, Igarashi N, Sakata R, Aihara M. Effects of selective EP2 receptor agonist, omidenepag, on trabecular meshwork cells, Schlemm's canal endothelial cells and ciliary muscle contraction. Sci Rep 2021;11:16257. [PMID: 34376747 DOI: 10.1038/s41598-021-95768-z] [Reference Citation Analysis]
65 Pol S, Upasani SD. Glaucoma in Pregnancy: Know What Next!! J Obstet Gynecol India. [DOI: 10.1007/s13224-021-01581-z] [Reference Citation Analysis]
66 Sen S, Das M, Singh Chugh TM. Angle Closure with Patent Laser Peripheral Iridotomy - An Unusual Complication. Int J Appl Basic Med Res 2021;11:270-2. [PMID: 34912693 DOI: 10.4103/ijabmr.IJABMR_733_20] [Reference Citation Analysis]
67 Stoner A, Harris A, Oddone F, Belamkar A, Verticchio Vercellin AC, Shin J, Januleviciene I, Siesky B. Topical carbonic anhydrase inhibitors and glaucoma in 2021: where do we stand? Br J Ophthalmol 2021:bjophthalmol-2021-319530. [PMID: 34433550 DOI: 10.1136/bjophthalmol-2021-319530] [Reference Citation Analysis]
68 Kudsieh B, Fernández-Vigo JI, Agujetas R, Montanero JM, Ruiz-Moreno JM, Fernández-Vigo JÁ, García-Feijóo J. Numerical model to predict and compare the hypotensive efficacy and safety of minimally invasive glaucoma surgery devices. PLoS One 2020;15:e0239324. [PMID: 32991588 DOI: 10.1371/journal.pone.0239324] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
69 Kimura T, Matsumoto C, Nomoto H. Comparison of head-mounted perimeter (imo®) and Humphrey Field Analyzer. Clin Ophthalmol 2019;13:501-13. [PMID: 30936681 DOI: 10.2147/OPTH.S190995] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
70 Watanabe M, Ida Y, Furuhashi M, Tsugeno Y, Ohguro H, Hikage F. Screening of the Drug-Induced Effects of Prostaglandin EP2 and FP Agonists on 3D Cultures of Dexamethasone-Treated Human Trabecular Meshwork Cells. Biomedicines 2021;9:930. [PMID: 34440134 DOI: 10.3390/biomedicines9080930] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Bartelt-Hofer J, Flessa S. Comparative efficacy and cost-utility of combined cataract and minimally invasive glaucoma surgery in primary open-angle glaucoma. Int Ophthalmol 2020;40:1469-79. [PMID: 32185590 DOI: 10.1007/s10792-020-01314-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]